Prognostic value of CA 125 in transitional cell carcinoma of the bladder. Read more about Prognostic value of CA 125 in transitional cell carcinoma of the bladder.
Emerging biological observations in prostate cancer. Read more about Emerging biological observations in prostate cancer.
Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy. Read more about Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy.
Use of APO2L/TRAIL with mTOR inhibitors in the treatment of glioblastoma multiforme. Read more about Use of APO2L/TRAIL with mTOR inhibitors in the treatment of glioblastoma multiforme.
Sipuleucel-T (APC8015) for prostate cancer. Read more about Sipuleucel-T (APC8015) for prostate cancer.
Oncolytic adenoviruses as antiglioma agents. Read more about Oncolytic adenoviruses as antiglioma agents.
Laparoscopic surgery for melanoma metastases to the adrenal gland. Read more about Laparoscopic surgery for melanoma metastases to the adrenal gland.
Targeting epidermal growth factor receptor: novel therapeutics in the management of cancer. Read more about Targeting epidermal growth factor receptor: novel therapeutics in the management of cancer.
